Skip to content
Temple University logo

Innovation Nest (iNest)

Visit program ↗Check the fit ↓
About the program · 1 linked sources

An 8,000+ sq ft innovation center and incubator under the Office of the Vice President for Research, opened March 2024 at 3223 N. Broad St., Suite 490. Focused on supporting research-based initiatives and commercialization while catalyzing North Philadelphia innovation. Features customizable wet/dry lab and office spaces. Three pillars: Innovate, Incubate, Collaborate.

Also known as: iNest

How we know this: the figures on this page come from the linked sources (last verified 2026-06-24); what those sources do not state is left unknown.

Key numbers

Funding range

Not listed

Equity

None

Application

Rolling

Campus Wide

Last activity

2026-06-24

High confidence

Keep this on your radar Deadline reminders ↓

Reminders

Innovation Nest (iNest)

Get an email before a director-verified deadline for this program, this school, or this state. The program never sees your address.

Student experiences · Read or add a note

Student notes

Innovation Nest (iNest)

No posts yet.

    Post what happened. A .edu account is required. Your name and email stay off this page.

    Rating

    0/280

    Application and Timing

    Incubation ongoing. Launched March 2024 with continued operations through 2025-2026. Intake appears rolling rather than cohort-only.

    Participants

    Temple researchers, faculty, student innovators, alumni, and community entrepreneurs in North Philadelphia. Positioned as connector between campus and local ecosystem.

    Funding and Equity

    Provides incubation, mentoring, and navigation to commercialization pathways including licensing and startup formation. Direct fund size not publicly enumerated. No equity at the iNest facility level.

    Recent Activity

    • Mar 2024: Grand opening with Philadelphia Mayor Cherelle Parker.
    • Nov 2024: Named Technical.ly Power Move of the Year.
    • Feb 2025: State senators celebrated $750K investment for life-saving medical device developed at iNest.
    • 2025-2026: Active incubation of multiple spinouts (Thrombolex, SFA Therapeutics, Inovele, Oral Biolife).

    Known Startups or Winners

    • Thrombolex — Temple spinout — BASHIR Endovascular Catheter (pulmonary embolism treatment).
    • SFA Therapeutics — drugs from human metabolites (autoimmune disease, cancer).
    • Inovele — safer EV batteries.
    • Oral Biolife — Ambrilux Dental Gel (bone regeneration).
    Research gaps & things to verify

    Verification Gaps

    • Specific incubator capacity and number of current resident startups.
    • Funding amounts available to incubated companies.
    Additional research notesShow

    Evidence

    • Official iNest page documenting facilities, contact, and featured startups.[1]
    • Research report.[2]